{
    "laboratory_examinations": [
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "September 1963",
            "findings": "Hypercellular with 95 percent myeloperoxidase-positive blast cells, confirming diagnosis of AML without maturation (FAB subtype M1).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "February 2003",
            "findings": "Hypercellular with 30 percent myeloperoxidase-positive blast cells containing Auer rods, indicating AML subtype M2 with eosinophilia (M2Eo). Cytogenetic evaluation revealed no abnormalities.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone marrow aspirate",
            "date": "Week after February 2003",
            "findings": "Normocellular with 35 percent myeloperoxidase-positive blast cells containing Auer rods, indicating AML subtype M2Eo. Cytogenetic evaluation revealed no abnormalities.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "DNA mutation analysis (CEBPA)",
            "date": "At diagnosis (February 2003)",
            "findings": "Mutation involving deletion of a cytosine residue at nucleotide 212 of CEBPA (212delC) in both Patients III-1 and III-5.",
            "changes_over_time": "Identical mutation was absent in germ-line DNA and blood samples taken during remission for both patients."
        },
        {
            "procedure_name": "DNA mutation analysis (CEBPA)",
            "date": "During remission",
            "findings": "212delC mutation detected in peripheral-blood samples from Patients III-1 and III-5, but the duplication was undetectable in Patient III-1's sample.",
            "changes_over_time": "Absent from germ-line DNA and not found in any samples from Patients II-3 and III-5."
        }
    ]
}